Randomized single-blinded non-inferiority trial of 7 mg/kg pentamidine isethionate versus 4 mg/kg pentamidine isethionate for cutaneous leishmaniaisis in Suriname

PLoS Neglected Tropical Diseases
Ricardo V P F HuRudy F M Lai A Fat

Abstract

Standard treatment of cutaneous leishmaniasis (CL) in Suriname entails three injections of pentamidine isethionate (PI) 4 mg/kg per injection in 7 days (7 day regimen). Compliance to treatment is low and may contribute to increasing therapy failure. A 3 day regimen, including 2 injections of 7 mg/kg in 3 days may increase compliance. In a randomized, single-blinded non-inferiority trial conducted in Suriname, 84 CL patients received the 7 day regimen and 79 CL patients received the 3 day regimen. Primary objective was the proportion of patients clinically cured at 6 weeks follow-up. Secondary objectives were clinical cure at 12 weeks follow-up; parasitological cure at 6 and 12 weeks; adverse and drug related toxicity events recorded one week after the end of treatment and health related quality of life. The non-inferiority margin was set at 15%, 1 sided test, α = 0.1. At 6 weeks follow-up 31 (39%) patients in the 3 day regimen and 41 (49%) patients in the 7 day regimen were clinically cured. Intention to treat (ITT) analyses showed that the difference in proportion clinically cured was -9.6% (90% Confidence Interval (CI): -22.3% to 3.2%). Per protocol (PP) analysis showed that the difference in proportion clinically cured was 0...Continue Reading

References

Mar 1, 1990·Journal of Clinical Microbiology·R BoomJ van der Noordaa
Nov 1, 1996·The Journal of Investigative Dermatology·M M ChrenS J Zyzanski
Mar 16, 2002·International Journal of Dermatology·Mehmet Salih GurelHatice Ozbilge
Nov 28, 2002·International Journal of Dermatology·Esther J S K Lai A FatRudy F M Lai A Fat
Jun 19, 2003·Diagnostic Microbiology and Infectious Disease·Jutta MarfurtIngrid Felger
Jan 19, 2006·Clinical Microbiology Reviews·Simon L CroftAlan H Fairlamb
Mar 9, 2006·JAMA : the Journal of the American Medical Association·Anne Le HenanffPhilippe Ravaud
Apr 7, 2007·Journal of Hepatology·Erik Christensen
Apr 29, 2008·Emerging Infectious Diseases·Wendy van der MeideLeslie Sabajo
Oct 30, 2008·PLoS Neglected Tropical Diseases·Masoom KassiPashtoon Murtaza Kasi
Jan 8, 2009·International Journal of Dermatology·Wendy F van der MeideRudy F M Lai A Fat
Mar 30, 2010·The American Journal of Tropical Medicine and Hygiene·Pieter-Paul A M van ThielAldert Bart
Jul 8, 2010·Journal of Global Infectious Diseases·David M Claborn
May 20, 2011·The Journal of Investigative Dermatology·Cecilia A C PrinsenJohn de Korte
Jan 13, 2012·The Journal of Infectious Diseases·Luisa Consuelo RubianoNancy Gore Saravia
May 5, 2012·The American Journal of Tropical Medicine and Hygiene·Ricardo V P F HuRudy F M Lai A Fat
Mar 12, 2013·Transactions of the Royal Society of Tropical Medicine and Hygiene·Antonio Carlos de Castro ToledoAna Rabello

❮ Previous
Next ❯

Citations

Aug 28, 2020·The Cochrane Database of Systematic Reviews·Mariona PinartJohn A Tweed
Feb 26, 2019·PLoS Neglected Tropical Diseases·Freddie BaileyDavid H Molyneux

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy
biopsies
Nucleic

Software Mentioned

STATA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.